Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2020, Oregon became the first locale to decriminalize psilocybin and legalize it for therapeutic use on a statewide basis. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8]

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

FEBRUARY 10, 2022

Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). By Allison Campbell.

DEA 52

DEA Clinical Trials Policy Research and Development 52

Canna Law Blog

OCTOBER 27, 2020

Legal psilocybin in Oregon? As a refresher, Measure 109 would legalize the manufacture, delivery and administration of psilocybin, but only at supervised, licensed facilities. The Oregon program will not square with federal laws. We like the sound of that. But do we unconditionally and unapologetically love the ballot measure?

DEA 79

DEA Decriminalization Research and Development Programs 79

MedicalJane

JUNE 29, 2018

Of those, nine states and DC have went a step further and legalized marijuana for all adults 21 and over. There is no universal handbook for a medical cannabis program. You will find that the requirements for becoming a legal medical cannabis patient vary from state to state, especially with regard to qualifying conditions.

Patients 83

Patients Legalization Conditions Treatment 83

Veriheal

DECEMBER 28, 2021

D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted. Many of these medical conditions are featured on the list of qualifying criteria for medical cannabis programs in the 37 U.S.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

The Blunt Truth

OCTOBER 3, 2019

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. Could it be the next state to legalize? Plus, a new bill would legalize cannabis with state-run stores. In Arizona , supporters of legalization have changed their ballot initiative language.

Chronic Pain 77

Chronic Pain Hemp DEA Programs 77

Veriheal

NOVEMBER 11, 2023

Many states in the US have legalized cannabis, thirty-eight states to be exact. According to the United States Drug Enforcement Administration (DEA), Schedule One drugs are “drugs with no currently accepted medical use and a high potential for abuse.” Is Medical Cannabis Legal? tetrahydrocannabinol (THC) are legal.

Law 62

Law Chronic Pain Conditions Legislation 62

Cannabis Law Report

NOVEMBER 9, 2019

Alexandria Ocasio-Cortez (D-NY) called for decriminalizing the use of and research on psychedelics, as well as comprehensive marijuana legalization, in a video message played for a drug policy reform conference on Thursday.

Decriminalization 45

Decriminalization DEA Policy Events 45

CannaMD

AUGUST 8, 2020

But CBD’s real calling card is that it’s popularly isolated from marijuana’s sibling plant, hemp , and can be legally sold (in most states) under much more relaxed regulations. One big myth is that the Farm Bill makes hemp-derived CBD legal. However, there are a number of restrictions. CBD Scheduling Rule Change.

CBD 99

CBD DEA Research and Development Hemp 99

Veriheal

APRIL 11, 2022

He also emphasized the fact that medical cannabis programs are now legal in 37 states, as well as four out of five inhabited U.S. The company initiated the first legal transfer (as deemed by federal law) to the U.S. Drug Enforcement Agency (DEA). territories. What Cannabis-Based Medicines Have Been Approved So Far?

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

MedicalJane

JUNE 29, 2018

The new drug is indicated for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. It is also the first FDA approval of a drug for the treatment of patients with Dravet syndrome. The Next Move Is On The DEA.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

Cannabis Law Report

JULY 9, 2021

Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. Drug Enforcement Agency (“DEA”). Id ; 21 CFR 312.1-10; 10; 312.80-88; 88; 312.300 et seq.

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

MARCH 2, 2020

The global march toward cannabis legalization has seemingly awoken another long dormant area of scientific interest: psychedelics as medicine. Food and Drug Administration (FDA) granted Breakthrough Therapy designation (BTD) to Compass Pathways ‘ psilocybin therapy for treatment-resistant depression. In 2018, the U.S.

Medicine 59

Medicine Therapy DEA Pharmaceutical 59

CannaMD

SEPTEMBER 15, 2020

Either way, it’s important you stay up to date with Florida’s rapidly evolving legal landscape: Can you use medical marijuana at work? What law legalized medical marijuana in Florida? To fully understand this definition, you also need to know two other legal definitions: Medical marijuana treatment center.

Law 126

Law Marijuana Patients Treatment 126

Veriheal

AUGUST 31, 2020

Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”. Program between St. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

JULY 27, 2021

UC Davis consistently ranks as one of the top plant sciences programs in the world and shares our commitment to applying a deeper scientific rigor to cannabis research in order to further our understanding behind the potentially life-saving applications of cannabinoid medicine. About Biopharmaceutical Research Company.

Research and Development 98

Research and Development Pharmaceutical Sativa Extraction 98

Cannabis Law Report

APRIL 14, 2022

Cannabis cultivation and processing are rapidly-growing industries, as hemp and both recreational and medical marijuana products are being legalized across the country. With this rapid growth and legalization, however, comes added regulatory scrutiny, including in the environmental and sustainability spaces. Larkin , Sheryl Sweeney.

Environment 52

Environment Agriculture Compliance Compliance 52

Cannabis Law Report

JULY 30, 2021

On July 14, 2021, Senators Chuck Schumer (D-NY), Ron Wyden (D-OR), and Cory Booker (D-NJ) released the discussion draft of historic federal cannabis legalization legislation, the Cannabis Administration and Opportunity Act (CAOA). This means the CAOA would historically legalize all cannabis and remove it from CSA control.

Hemp 105

Hemp Law Seed-To-Sale Food 105

Canna Law Blog

SEPTEMBER 28, 2019

Not long ago we wrote about a decision by the Second Circuit that may force the DEA to re- or deschedule marijuana after writing about the lawsuit when it was first filed last year. IDEA requires that schools provide special education services as outlined in a student’s Individualized Education Program (“IEP”).

Education 61

Education Oil DEA Cannabis 61

SpeedWeed

MARCH 5, 2021

One, they have been determined by the US Food and Drug Administration to be clinically safe and effective treatments for a specific medical condition. Two, they are federally classified by DEA and HHS as Schedule II, III, IV or V substances. By Paul Armentano. Congress has recently descheduled low-THC cannabis plants.

Business 52

Business Policy Clinical Trials Research and Development 52

PrestoDoctor

JANUARY 14, 2020

They are responsible for giving you information about the treatment and proper use. Who Monitors This Program in Oklahoma? The Oklahoma Medical Marijuana Authority (OMMA) manages the MMJ program for the State of Oklahoma. This agency oversees licensing, regulation, and administration of the program.

Marijuana 52

Marijuana Patients Conditions Programs 52

PrestoDoctor

JANUARY 14, 2020

They are responsible for giving you information about the treatment and proper use. Who Monitors This Program in Oklahoma? The Oklahoma Medical Marijuana Authority (OMMA) manages the MMJ program for the State of Oklahoma. This agency oversees licensing, regulation, and administration of the program.

Marijuana 52

Marijuana Patients Conditions Programs 52

Canna Law Blog

OCTOBER 23, 2020

Drug Enforcement Administration (“DEA”) to reschedule marijuana. As we all know, the DEA has routinely refused to accept or denied each and every petition, minus one that yielded very specific changes for a synthetic cannabis drug. Per the usual course, the DEA filed a motion to dismiss for failure to exhaust administrative remedies.

DEA 70

DEA Policy History Treatment 70

Veriheal

JUNE 29, 2021

In order to legally access other therapies including nature-based options such as psilocybin , you must gain access under a Right to Try law which requires you to have a terminal condition. The FDA refers to this program as the expanded access program on their website. Patients Are Not In This Alone.

Therapy 56

Therapy DEA Patients Clinical Trials 56

CannaMD

SEPTEMBER 10, 2020

But despite these revelations, both messaging and legalities have lagged. In a national landscape in which two-thirds of Americans support legalization of marijuana, it’s not surprising that a small but growing number of pregnant women report cannabis use prior to and during pregnancy. WHO USES CANNABIS DURING PREGNANCY AND WHY?

Marijuana 59

Marijuana Therapy Data THC 59

Canna Law Blog

MAY 7, 2020

Ole Miss got the cannabis study and research cultivation gig from the DEA (via a contract with the National Institute on Drug Abuse (NIDA)) in 1968. This was before implementation of the federal government’s Compassionate Investigational New Drug Program (CINDP), which Ole Miss’s grow now serves in addition to its research.

DEA 70

DEA Research and Development Cultivation Supply Chain 70

CannaMD

NOVEMBER 15, 2020

research on marijuana harms – such as cannabis withdrawal, treatments for substance abuse and use/exposure during pregnancy or infancy – received 20 times more funding than research on cannabis therapeutics. While some funds are being used to study cannabis medical treatments, the majority of funding is still used to research harms.

DEA 105

DEA Clinical Trials Cannabinoids Treatment 105

Cannabis Law Report

JULY 1, 2021

In 2017, the FDA designated MDMA a breakthrough therapy for post-traumatic stress disorder, and in 2018 the agency recognized psilocybin as a breakthrough therapy for treatment-resistant depression. These designations indicate that psychedelics may represent substantial improvements over existing treatments for mental health conditions.

Law 105

Law Research and Development Therapy DEA 105

Cannabis Law Report

SEPTEMBER 12, 2022

Government Agencies seek funding to research cannabinoids as treatments for various conditions: [link]. Delta 8 now legal in Kentucky: [link]. Virginia 2024 adult use program may be postponed: [link]. Columbia considering legalizing cannabis: [link]. Cannabinoids. Does Delta 8 show up on a drug test? [link].

DEA 98

DEA Dispensary Hemp Therapy 98

Cannabis Law Report

APRIL 8, 2022

as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. Now, we are closer than ever to legalizing MDMA-assisted therapy for posttraumatic stress disorder (PTSD), though there is still a long road ahead. MAPS Founder Rick Doblin, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

SEPTEMBER 23, 2019

The AAFP urges its members to be involved in the diagnosis, treatment, and prevention of substance use, as well as secondary diseases impacted or caused by use. The AAFP recognizes the benefits of intervention and treatment for the recreational use of marijuana, in lieu of incarceration, for all individuals, including youth.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

APRIL 13, 2022

market presence, complementary client programming and respected clinical research capabilities allow us to accelerate our strategic growth plans and broaden access to healing and wellness.” Increased client programming with complementary service offerings to be shared and expanded across the combined clinic network.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

The Cannigma

SEPTEMBER 12, 2021

The reason these two cannabinoids have become so popular in the United States is because of a legal contradiction created by the 2018 Farm Bill, which declared products derived from hemp to be legal. Is THC legal in the US? As is often the case with cannabis, the question of legality can be confusing.

THC 98

THC Research and Development Cannabinoids CBD 98

The Cannigma

FEBRUARY 16, 2022

SP: Yeah, my focus was how do you get into business legally, without having to stand in line and wait for a license from the government? If people don’t know here, it’s been two years since we started legal cannabis use, there’s zero social equity licenses, business holders that have started.

Trichome 73

Trichome Wellness and Beauty Cannabinoids Cannabis 73

The Cannigma

MAY 15, 2023

While costs to access ketamine therapy can be high in some locations, and like any drug ketamine is not a cure-all, some patients and their doctors have been reporting life-changing results when no other treatment provided relief. Patients may want to seek assistance from a certified professional prior to embarking on treatment.

Therapy 78

Therapy Access Blood Pressure Treatment 78

NORML

FEBRUARY 18, 2020

The latest offense is his recently released 2021 federal budget proposes slashing all legal protection for state medical marijuana programs and potentially jeopardizing the patients that rely on them. Sign our petition to demand Congress protect state-legal medical marijuana programs. The data speaks for itself.

Marijuana 355

Marijuana DEA Programs Patients 355

Canna Law Blog

MARCH 7, 2023

EB-5 program. The INA contains an immigrant investor program at 8 USC § 1153(b)(5) that allows foreign nationals to apply for permanent residence by making a minimum investment in a new commercial enterprise in the U.S. The program, known as “EB-5”, is much more complex but for or purposes here that will do. Bright Green Corp.,

DEA 69

DEA Research and Development Programs Cannabis 69